Home
About Us
Company News
Contact Us
Expanded Access Program
Home
About Us
Company News
Contact Us
Expanded Access Program
中文/EN
Company News
In the Press
Learn More
2024-08-20
Organoid disease models + AI empowerment, the world's first targeted drug for diffuse gastric cancer receives FDA IND approval
Learn More
2024-08-13
First expansion to Shenzhen! 2024 "Life Science Summer Internship Program" sets new participation record
Learn More
2023-09-21
Exclusive Interview | Organoids, a better substitute for animal testing, are becoming a hot spot for major pharmaceutical companies
Learn More
News
Learn More
2025-03-11
Signet Therapeutics to attend BIOCHINA2025, discussing the future of biopharmaceutical innovation together
Learn More
2025-03-10
Signet Therapeutics awarded "Organoid Technology Breakthrough Award" by Bio Valley
Learn More
2025-03-07
Signet Therapeutics' SIGX1094 joins the US FDA Compassionate Use Program, helping patients with serious diseases access drug treatment as soon as possible
Learn More